Sheng-Xiang Lin
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Endocrinologie et génomique
- Adresse
- 2705, boulevard Laurier, T-4-50
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-525-4444, poste 42296
- Télécopieur
- +1 418-654-2298
- Courriel
- Sheng-Xiang.Lin@crchul.ulaval.ca
Projet(s) de recherche reconnu(s) par l'Université Laval
Autre(s) projet(s) de recherche actif(s)
Aucun projet de recherche à afficher
Publications récentes (voir toutes les publications de ce chercheur)
Adjo Aka J, Lin SX. Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7. PLoS ONE,
2012. 7: e31532
Gilbert C, Azzi A, Goyette N, Lin SX, Boivin G. Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet. Antimicrobial agents and chemotherapy,
2011. 55: 4019-27
Zhang SC, Sun M, Li T, Wang QH, Hao JH, Han Y, Hu XJ, Zhou M, Lin SX. Structure analysis of a new psychrophilic marine protease. PLoS ONE,
2011. 6: e26939
Ding FX, Xu YF, Azzi A, Zhu DW, Rehse P, Chen CQ, Sun SH, Lin SX. Crystallization of the Membrane-Associated Annexin B1: Roles of Additive Screen, Dynamic Light Scattering, and Bioactivity Assay Crystal growth and design,
2010. 10: 2528-2532
Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX. 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. Molecular endocrinology (Baltimore, Md.)
,
2010. 24: 832-45
Martin M, Azzi A, Lin SX, Boivin G. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity. Antiviral therapy,
2010. 15: 579-86
Lin SX, Chen J, Mazumdar M, Poirier D, Wang C, Azzi A, Zhou M. Molecular therapy of breast cancer: progress and future directions. Nature reviews. Endocrinology,
2010. 6: 485-93
Azzi A, Wang T, Zhu DW, Zou YS, Liu WY, Lin SX. Crystal structure of native cinnamomin isoform III and its comparison with other ribosome inactivating proteins. Proteins,
2009. 74: 250-5
Aka JA, Mazumdar M, Lin SX. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. Molecular and cellular endocrinology,
2009. 301: 183-90
Mazumdar M, Fournier D, Zhu DW, Cadot C, Poirier D, Lin SX. Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy. The Biochemical journal,
2009. Epub
